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842-3 Blunted Erythropoietin Production and Defective Iron 
Supply for Erythropoiesis as Major Causes of Anemia in 
Patients With Chronic Heart Failure
Cristina Opasich, Mario Cazzola, Stefania De Feo, Enzo Bosimini, Rocco La Gioia, 
Oreste Febo, Roberto Ferrari, Gloria Francolini, Remiglio Moratti, Laura Scelsi, Maurizio 
Volterrani, Roberto Tramarin, Luigi Tavazzi, Fondazione Salvatore Maugeri, Pavia, Italy, 
Policlinico San Matteo, Pavia, Italy
BACKGROUND Recent studies have shown that anemia is a common comorbid condi-
tion in patients with chronic heart failure (CHF), suggesting an impact on history and
prognosis.
AIM To investigate the mechanisms of anemia in a series of consecutive anemic CHF
patients and define a rational therapeutic approach.
METHODS A series of 148 consecutive adult CHF pts with Hb <13 g/dL (males) or <12
g/dL (females) was studied. Potential responsible factors for anemia were investigated by
evaluating endogenous erythropoietin (Epo) production, serum cytokines levels (TNF-
alpha and its soluble receptors, IL-6 and IL-1Ra), body iron status, and iron supply for
erythropoiesis.
RESULTS 105 pts (71%) had evidence of severe defective endogenous erythropoietin
production, indicated by an observed/predicted log(serum Epo) ratio <0.8; 85 pts (57%)
had low serum iron (mean value for men 105, for women 45 ng/mL; 61 (41%) had low
transferrin saturation (mean value 22% for men and 23% for women) and 85 (57%) had
increased levels for soluble transferrin receptor. Impaired iron supply to erythropoiesis, as
indicated by low transferrin saturation and/or increased values for soluble transferrin
receptor, was observed in 105 pts (71%). Elevated values for high sensitivity C-reactive
protein (mean value 0.69 for men and 0.61 mg/dL for women) were found in 83 pts
(56%), increased serum creatinine in 44 pts (30%), cytokines activation in 133 pts (90%).
CONCLUSION Our findings demonstrate that the vast majority of anemic CHF pts shows
evidence of blunted endogenous erythropoietin production and/or defective iron supply
for erythropoiesis. Therefore, the assessment of serum erythropoietin and the evaluation
of body iron status represent a rational approach to treatment of the individual patient:
according to those physiopathologic findings in most instances, subcutaneous adminis-
tration of recombinant human erythropoietin combined with iv iron would represent the
optimal therapeutic approach.
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842-4 Deranged Steroid Metabolism Independently Predicts 
Anemia in Chronic Heart Failure
Darlington O. Okonko, Martino Crosato, Paul R. Kalra, Mariantonietta Cicoira, Wolfram 
Steinborn, Wolfram Doehner, Phillip A. Poole-Wilson, Andrew J. Coats, Stefan D. Anker, 
Imperial College, National Heart and Lung, London, United Kingdom, Applied Cachexia 
Research, Charité, Virchow-Klinikum, Berlin, Germany
Background: The pathogenesis of anemia in chronic heart failure (CHF) is poorly under-
stood. It may be secondary to abnormalities in CHF. Adrenal metabolism in CHF is char-
acterised by the predominance of catabolic (cortisol) over anabolic (androgen) steroids.
As erythropoiesis is normally stimulated by androgens and can be depressed by chronic
cortisol excess, we hypothesised that the steroid imbalance in CHF may contribute to
anemia.
Methods: We assessed the relationship between plasma hemoglobin and the cortisol/
DHEA ratio (CDR) in 92 male CHF patients. CDR values are log-transformed.
Results: Mean age of patients was 61±11 y, body mass index 26.3±4.5 kg/m2, NYHA
class 2.6±0.7, peak oxygen consumption(VO2) 18.1±6.0 mL/kg/m2, ventilation/carbon
dioxide production slope 38±13, left ventricular ejection fraction 25±11%, urate 473±139
µmol/L, cortisol 410±12 nmol/L, DHEA 13.3±9.1 nmol/L, logCDR 1.57±0.33 (range: 0.89-
2.53), Cockroft-Gault calculated glomerular filtration rate (GFRc) 111±50 mL/min. 13
patients (14%) were anemic (hemoglobin < 12 g/dL, microcytic: 1 [8%], macrocytic: 1
[8%]). Anemic patients were older, with lower peak VO2, lower GFRc, higher urate and
higher logCDR (all p<0.001). In univariate regression analysis, determinants of hemoglo-
bin were logCDR (r=-.41, p<0.0001), GFRc (r=0.36, p=0.0004), body mass index (r=0.32,
p=0.002), age (r=-0.30, p=0.004), serum urate (r=-0.27, p<0.02) and peak VO2 (r=0.26,
p<0.02). Only CDR and GFRc remained independent predictors of hemoglobin on step-
wise regression analysis (1. step: partial correlation for logCDR =-0.43, F=19.6; 2. step:
partial correlation for GFRc =0.28, F=8.3; joint R=0.51). The relationship between CDR
and hemoglobin in patients with impaired exercise capacity (peak VO2<18) was stronger
than in those with preserved exercise capacity (peak VO2>18) (r=0.45, p<0.002 vs
r=0.21, p=0.18, respectively).
Conclusion: Altered steroid metabolism, as measured by the cortisol/DHEA ratio, is a
strong independent predictor of hemoglobin levels in male CHF patients. This relation-
ship strengthens with disease severity, further suggesting an etiological link between
anemia and steroid imbalance in CHF.
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Heart Failure Population)
Lynne E. Wagoner, Javed Butler, Ron Oren, Jalal K. Ghali, Ileana Pina, Alan Miller, J. 
Herbert Patterson, Mick O'Quigley, Carla A. Sueta, Michael James, Shaival Kapadia, 
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Background. Extent of anemia and factors associated with reduced hemoglobin (Hgb) in
randomly selected outpatients (Pts) with heart failure (HF) have not been well described.
Methods. Anemia in HF was evaluated from the STAMINA-HFP Registry, a prospective,
observational study enrolling randomly selected Pts from 12 specialty and 45 community
cardiology clinics. The following characteristics were tested for their association with ane-
mia (Hgb <12 g/dl for females; <13 g/dl for males): age, NYHA class, blood pressure,
pulse, estimated glomerular filtration rate (eGFR), hypertension, diabetes, chronic
obstructive lung disease, current smoking, and angiotensin converting enzyme inhibitor
or beta blocker use. Anemia status was available in 982 (326 specialty; 656 community)
of the 1089 Pts enrolled, who were 41% female, 75% Caucasian with an age (mean
±SD) of 64±14 years.
Results. Anemia was present in 33% and its frequency was similar in specialty and com-
munity sites (32 vs. 34%, p=0.675). Mean Hgb was 13.3±1.8 g/dl (median 13.3 g/dl).
Lower eGFR, higher NYHA class, male gender, lower diastolic blood pressure, higher
systolic blood pressure, and African-American ethnicity were predictors of anemia (all
others p>0.15). Significant predictors of anemia are shown. 
Conclusion. Anemia is common in randomly selected Pts with HF and is associated with 
standard clinical characteristics. This high prevalence supports efforts to investigate the 
potential beneficial effect of correcting anemia in Pts with HF.
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842-6 Anemia Is Associated With Reduced Health Status 
Measures in Patients With Heart Failure: Results From 
the STAMINA:HFP (Study of Anemia in a Heart Failure 
Population) Registry
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Stephanie H. Dunlap, Todd A. Schwartz, Wendy A. Gattis, Mandeep R. Mehra, Jalal K. 
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Background. Anemia is associated with adverse outcomes in heart failure (HF). How-
ever, the relationship of hemoglobin (Hgb) to quality of life (QoL) in outpatients with HF is
unknown.
Methods. The association between QoL and Hgb in HF was assessed in the STAMINA-
HFP Registry, a prospective, observational study enrolling randomly selected patients
from HF specialty clinics involved in the UNITE-HF database or from community cardiol-
ogy practice clinics. QoL was prospectively determined by telephone contact at baseline
for the Kansas City Cardiomyopathy Questionnaire (KCCQ) - higher score reflects better
QoL and Minnesota Living with Heart Failure (MLHF) Questionnaire - lower score reflects
better QoL. Anemia was defined as a Hgb <12 g/dl in females and <13 g/dl in males.
Results. Baseline Hgb, gender and QoL data were available in 780 (249 specialty, 531
community) of the 1089 patients enrolled in the registry. The cohort was 42% female,
77% Caucasian, with an age (mean±SD) of 64 ± 14 years. Mean Hgb was 13.2 ± 1.8 g/
dl. Significant relationships between QoL and Hgb, as a continuous variable, remained
after adjusting for age, gender, race, diabetes, NYHA class and LVEF for KCCQ scores
(all p<0.05) and for Physical and Summary MLHF scores (p<0.03) after adjustment for all
these variables except NYHA class. 
Clinical Characteristic Odds Ratio
for anemia
95% CI P
eGFR* per 10ml/min 0.79 0.74 - 0.85 <0.001
NYHA class per unit 1.31 1.06 - 1.61 0.011
Gender (female vs. male) 0.60 0.44 - 0.83 0.002
Ethnicity (African-American yes vs. no) 1.90 1.31 - 2.76 <0.001
DBP per 5mmHg 0.78 0.72 - 0.86 <0.001
SBP per 5mmHg 1.07 1.02 - 1.12 0.006
eGFR=estimated glomerular filtration rate, DBP=diastolic blood pressure, SBP=systolic 
blood pressure, CI = confidence interval.
*estimated using a form of the Modification of Diet in Renal Disease equation 
(incorporates age, gender, race, and serum creatinine)
